The global Supportive Care Agents drugs market size stood at USD 21.1 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The cancer supportive care products are the drugs administer during the cancer treatment to improve the health quality of patients. Cancer supportive care products are essential during the cancer chemotherapy treatment as the cancer treatment is associated with severe side effects. Cancer supportive care products are given to the patients to relieve, manage or prevent the adverse effects and accelerate the patient’s comfort during the cancer treatment. Increasing investment in the pharmaceutical sector is expected to offer lucrative growth opportunities for players in the global cancer supportive care products market. Moreover, R&D in cancer pain care is also expected to offer lucrative growth opportunities for players in the global cancer supportive care products market.
The growing cancer patient pool burden in developed as well as developing country is anticipated to accelerate the demand of cancer supportive care products. Consequently, it will help to bolster up the cancer supportive care products market growth. It is predicted that high prevalence and disease burden of cancer is a major driving factor for the growth of the cancer supportive care products market. The increasing side effects of cancer supportive care medication are acting as a restraint for hampering the demand of the cancer supportive care products market. The agreement and acquisition are the golden opportunity for the cancer supportive care products market players to elevate their revenue growth. The development of newer versions of the drug could significantly change the compound from the original compound.